Voigtlander Christian B. 4
4 · ICU MEDICAL INC/DE · Filed Mar 16, 2026
Research Summary
AI-generated summary of this filing
ICU Medical COO Christian Voigtlander Receives 14,648 Shares (Withheld 8,096)
What Happened
Christian B. Voigtlander, Chief Operating Officer of ICU Medical (ICUI), had performance- and time‑based restricted stock units convert to common shares on 2026-03-15. A total of 14,648 shares were issued to him (11,400 and 3,248 awards). To cover tax withholding, 8,096 of those shares were surrendered at $125.85 per share, totaling $1,018,882. Net new shares to Voigtlander after withholding were 6,552. The awards included PRSUs that vested at 117% of target.
Key Details
- Transaction date: 2026-03-15; Form 4 filed 2026-03-16 (timely).
- Awards converted: 14,648 shares (reported as derivative exercises/conversions).
- Shares withheld for taxes: 6,301 shares ($792,981) + 1,795 shares ($225,901) = 8,096 shares; withholding price used = $125.85/share; total ~$1,018,882.
- Net shares received by insider: 6,552 shares.
- Footnotes: PRSUs were performance-based (grant 3/15/2023) and certified at 117% of target by the Compensation Committee on 2/11/2026; RSUs/PRSUs have no exercise price.
- Filing does not list total shares owned after the transaction in the provided excerpt.
Context
- This was not an open‑market buy or sell but the settlement of restricted stock units (PRSU/RSU); such share issuances are routine compensation events rather than directional bets.
- The tax liability was satisfied via share withholding (a common cashless settlement method).
- No 10b5-1 plan, gift, or option purchase was reported; the conversion is reported under code M (exercise/conversion) and code F (payment of tax liability).
Insider Transaction Report
Form 4
Voigtlander Christian B.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2026-03-15+11,400→ 51,154 total - Tax Payment
Common Stock
2026-03-15$125.85/sh−6,301$792,981→ 44,853 total - Exercise/Conversion
Common Stock
[F3]2026-03-15+3,248→ 48,101 total - Tax Payment
Common Stock
2026-03-15$125.85/sh−1,795$225,901→ 46,306 total - Exercise/Conversion
Common Stock
[F3][F4]2026-03-15−3,248→ 0 totalExercise: $0.00From: 2026-03-15Exp: 2026-03-15→ Common Stock (3,248 underlying) - Exercise/Conversion
Performance Shares
[F1][F5][F2]2026-03-15−11,400→ 0 totalExercise: $0.00From: 2026-03-15Exp: 2026-03-15→ Common Stock (11,400 underlying)
Footnotes (5)
- [F1]These Securities are Performance-based Restricted Stock Units (PRSU).
- [F2]Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.
- [F3]These securities are Restricted Stock Units.
- [F4]There is neither a purchase price nor an exercise price for the Restricted Stock Units.
- [F5]There is neither a purchase price nor an exercise price for the PRSUs.
Signature
By: Paula Darbyshire, Attorney-in-Fact For: Christian Voigtlander|2026-03-16